Home/Filings/4/0001209191-23-016079
4//SEC Filing

Wisel Camela 4

Accession 0001209191-23-016079

CIK 0001627223other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:47 PM ET

Size

13.1 KB

Accession

0001209191-23-016079

Insider Transaction Report

Form 4
Period: 2023-03-01
Wisel Camela
VP, CAO & Controller
Transactions
  • Award

    Common Stock

    2023-03-01+2,15212,147.885 total
  • Award

    Stock Option (Right to Buy)

    2023-03-01+4,8824,882 total
    Exercise: $34.84Exp: 2033-03-01Common Stock (4,882 underlying)
  • Tax Payment

    Common Stock

    2023-03-02$36.12/sh487$17,59011,660.885 total
  • Tax Payment

    Common Stock

    2023-03-01$34.84/sh564$19,6509,995.885 total
  • Award

    Performance Stock Option (Right to Buy)

    2023-03-01+4,8134,813 total
    Exercise: $38.32Exp: 2033-03-01Common Stock (4,813 underlying)
Footnotes (5)
  • [F1]Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
  • [F2]Includes directly owned shares, restricted stock units and dividend equivalent units.
  • [F3]Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.
  • [F4]These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.
  • [F5]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

Issuer

Chemours Co

CIK 0001627223

Entity typeother

Related Parties

1
  • filerCIK 0001886003

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:47 PM ET
Size
13.1 KB